Ignite Creation Date:
2025-12-24 @ 1:06 PM
Ignite Modification Date:
2026-01-07 @ 6:51 AM
Study NCT ID:
NCT02711761
Status:
COMPLETED
Last Update Posted:
2016-07-11
First Post:
2016-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ideal Depth of Guide Wire for Central Catheterization
Sponsor:
Seoul National University Hospital
Organization:
Study Overview
Official Title:
Ideal Depth of Guide Wire for Right Internal Jugular Vein During Central Line Insertion
Status:
COMPLETED
Status Verified Date:
2016-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
prospective randomized double-blind controlled study
Detailed Description:
Total of 69 ASA (American Society of Anesthesiologist) physical status class I or II patients will be enrolled.
Randomly assigned to three group according to the depth of guide-wire prior to tissue dilation during central catheterization via right internal jugular vein. (Group 1: 15 cm / Group 2: 17.5 cm / Group 3: 20 cm)
Central catheterization will be performed by anesthesiologists who be blinded to this study protocol.
An investigator will monitor and record whether any arrhythmia will occur.
The incidence of occurrence of arrhythmia will be compared between three groups.
Randomly assigned to three group according to the depth of guide-wire prior to tissue dilation during central catheterization via right internal jugular vein. (Group 1: 15 cm / Group 2: 17.5 cm / Group 3: 20 cm)
Central catheterization will be performed by anesthesiologists who be blinded to this study protocol.
An investigator will monitor and record whether any arrhythmia will occur.
The incidence of occurrence of arrhythmia will be compared between three groups.
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: